Divalproex Sodium
Product Images NDC 53808-0356
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 53808-0356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Divalproex Figure 1 (3cd35eb6 Df66 4848 86dd F1fa47731057 02)
Divalproex Figure 2 (3cd35eb6 Df66 4848 86dd F1fa47731057 03)
This is a description of a study that involves the administration of two different doses of Divalproex sodium delayed-release tablets. The mean dose used in the first study was 1087 mg/day, while the second study used either 500 or 1000 mg/day. The text also includes the names of the placebo and the medication being used in the study.*
Divalproex Figure 3 (3cd35eb6 Df66 4848 86dd F1fa47731057 04)
Divalproex Figure 4 (3cd35eb6 Df66 4848 86dd F1fa47731057 05)
This text appears to be a chart or graph that shows the reduction in CPS rate. It seems to list different doses of a medication and their effects on patients. The percentage of patients who experienced improvement, no change, or worsening is also mentioned. However, without further context, it is difficult to interpret or provide a more detailed description.*
Divalproex Sodium Delayed-release Tablets 250 mg (Divalproex 250mg(mylan))
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.